We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy Subsidiary Ohm Receives GMP Warning
Ranbaxy Subsidiary Ohm Receives GMP Warning
February 2, 2010
Ranbaxy Laboratories subsidiary Ohm Laboratories has received a warning letter for GMP violations at its facility for making oral solutions.